about
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapyEfficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft modelLoss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDiagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probeProline oxidase functions as a mitochondrial tumor suppressor in human cancers.Proton pump inhibitors for the treatment of cancer in companion animals.A bioreactor model of mouse tumor progression.Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?Role of cellular bioenergetics in smooth muscle cell proliferation induced by platelet-derived growth factor.Tumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in ApcMin mouse model of colon cancer.Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma.Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.Mammary serine protease inhibitor inhibits epithelial growth factor-induced epithelial-mesenchymal transition of esophageal carcinoma cells.Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers.Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes.
P2860
Q27015257-B43C648B-4721-44E7-923F-679C2C0AD8AAQ28482093-C1DA7798-DEAF-47F5-92E8-F023790EEE57Q34182618-77FC34B4-960E-49D8-800F-9294AF270ED9Q34783824-8184F57C-CC6D-4C9C-9B07-9D967E2EC562Q34872984-162E19FC-45D8-4206-A86B-B44668625BD4Q36027301-DD3C0F65-99E8-413A-92E5-2F8F9CE6E763Q36412780-7664A6B7-D741-49AB-B62C-5DE8C4E356C2Q36437195-06ECBA38-C2D9-465F-AB48-B12F86E1525EQ36808761-9917813C-92A3-4C0C-9955-C93CA21607DAQ37467514-9173A125-B772-4487-B52F-902F50E16CDCQ38980187-E4EE8287-0B9F-4567-A478-071A080AB9DCQ39160992-C9856284-6B72-41F9-B497-89DBED1BEDF2Q39904191-B008B7A0-DACD-4EDF-9004-92C9F1114D60Q39939406-4BB4FF77-F544-4F1F-BB63-01C30A2FA659Q50345931-955D7102-85B8-4D44-BDFA-C7F589EF46AA
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Tumor metabolism: new opportunities for cancer therapy.
@ast
Tumor metabolism: new opportunities for cancer therapy.
@en
type
label
Tumor metabolism: new opportunities for cancer therapy.
@ast
Tumor metabolism: new opportunities for cancer therapy.
@en
prefLabel
Tumor metabolism: new opportunities for cancer therapy.
@ast
Tumor metabolism: new opportunities for cancer therapy.
@en
P1476
Tumor metabolism: new opportunities for cancer therapy.
@en
P2093
Antonia Avila-Flores
Isabel Mérida
P2888
P304
P356
10.1007/S12094-006-0117-6
P577
2006-10-01T00:00:00Z